Precigen Provides Latest Clinical Developments at Virtual R&D Update Event
Search jobs Precigen Provides Latest Clinical Developments at Virtual R&D Update Event GERMANTOWN, Md., Dec. 15, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today held an R&D virtual event to provide an update on the latest progress for its clinical pipeline. The event showcased data from several of Precigen's most advanced clinical programs—PRGN-3005 UltraCAR-T®, PRGN-3006 UltraCAR-T® and AG019 ActoBiotics TM with presentat...
Source: pharmiweb.com